efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination and Sarcoma--Kaposi

efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination has been researched along with Sarcoma--Kaposi* in 1 studies

Other Studies

1 other study(ies) available for efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination and Sarcoma--Kaposi

ArticleYear
Human immunodeficiency virus-associated giant conjunctival Kaposi's sarcoma: complete remission with antiretroviral therapy and systemic chemotherapy.
    Archivos de la Sociedad Espanola de Oftalmologia, 2018, Volume: 93, Issue:6

    A 35-year-old male patient with a large unilateral haemorrhagic conjunctival tumour lesion and another contralateral haemorrhagic conjunctival flat lesion associated with violaceous cutaneous macules on the extremities and angiomatous lesions in the upper gastrointestinal tract as initial clinical manifestation of HIV-related immunodeficiency. Cutaneous, gastric mucosal and conjunctival biopsy was consistent with Kaposi's sarcoma with complete remission after highly active antiretroviral therapy and systemic chemotherapy.. HIV-related conjunctival Kaposi's sarcoma, even a large one, can have a good response to antiretroviral therapy and systemic chemotherapy without any additional topical eye treatment.

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Conjunctival Neoplasms; Doxorubicin; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Humans; Immunocompromised Host; Male; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms

2018